Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Eye Care

Journal Scan / Research · July 31, 2023

Efficacy and Safety of Low-Dose Atropine Eye Drops vs Placebo for Myopia Control

JAMA Ophthalmology


Additional Info

JAMA Ophthalmology
Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial
JAMA Ophthalmol 2023 Jul 13;[EPub Ahead of Print], MX Repka, KK Weise, DL Chandler, R Wu, BM Melia, RE Manny, LAF Kehler, CO Jordan, A Raghuram, AI Summers, KA Lee, DB Petersen, SA Erzurum, Y Pang, PD Lenhart, BH Ticho, RW Beck, RT Kraker, JM Holmes, SA Cotter

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading